Carvajal Alejandra
Insider CIK 1645755 · MNTA Chief Legal Officer · CERU VP, General Counsel · MRSN SVP, Chief Legal Officer · CTMX Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-08-03 | 2026-08-05 | 450,000 | — | $0 | 450,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2026-08-03 | 2026-08-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-08-03 | 2026-08-05 | 450,000 | — | $0 | 450,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2026-08-03 | 2026-08-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 4,922 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 3,047 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,500 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 717 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 100 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 7,921 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,078 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,166 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,527 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,800 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 4,500 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 6,702 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 3,131 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-16 | 2025-01-17 | 5,096 | $0.58 | $3.0K | 78,296 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-01-15 | 2025-01-17 | 243,750 | — | $0 | 243,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-01-15 | 2025-01-17 | 54,167 | — | $0 | 54,167 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-15 | 2025-01-17 | 12,500 | — | $0 | 37,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-15 | 2025-01-16 | 952 | $0.63 | $600 | 70,892 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-15 | 2025-01-17 | 12,500 | — | $0 | 83,392 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-14 | 2025-01-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-14 | 2025-01-15 | 3,330 | $0.66 | $2.2K | 69,344 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-14 | 2025-01-16 | 2,500 | — | $0 | 71,844 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-13 | 2025-01-15 | 8,958 | — | $0 | 17,917 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-13 | 2025-01-15 | 8,958 | — | $0 | 72,674 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2024-10-03 | 2024-10-07 | 5,598 | $1.96 | $11.0K | 63,716 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2024-10-02 | 2024-10-07 | 8,089 | $2.00 | $16.2K | 69,314 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-07 | 50,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-10-01 | 2024-10-07 | 50,000 | — | $0 | 77,403 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2024-01-16 | 2024-01-17 | 4,381 | $2.71 | $11.9K | 27,403 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-01-15 | 2024-01-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-01-15 | 2024-01-17 | 225,000 | — | $0 | 225,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-14 | 2024-01-17 | 2,500 | — | $0 | 5,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-14 | 2024-01-17 | 2,500 | — | $0 | 31,784 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-13 | 2024-01-17 | 8,958 | — | $0 | 26,875 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-13 | 2024-01-17 | 8,958 | — | $0 | 29,284 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-09-05 | 2023-09-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2023-04-27 | 2023-04-28 | 3,944 | $3.89 | $15.3K | 20,326 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2023-04-26 | 2023-04-28 | 13,250 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2023-04-26 | 2023-04-28 | 13,250 | — | $0 | 24,270 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2023-01-17 | 2023-01-18 | 782 | $5.74 | $4.5K | 11,020 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2023-01-14 | 2023-01-18 | 2,500 | — | $0 | 7,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2023-01-14 | 2023-01-18 | 2,500 | — | $0 | 11,802 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-01-13 | 2023-01-18 | 161,250 | — | $0 | 161,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-01-13 | 2023-01-18 | 35,833 | — | $0 | 35,833 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2022-04-26 | 2022-04-28 | 13,250 | — | $0 | 13,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2022-04-26 | 2022-04-28 | 3,948 | $3.69 | $14.6K | 9,302 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2022-04-26 | 2022-04-28 | 13,250 | — | $0 | 13,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-04-26 | 2021-04-28 | 112,500 | — | $0 | 112,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-04-26 | 2021-04-28 | 26,500 | — | $0 | 25,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 35,312 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 3,972 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 23,188 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 37,500 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 21,938 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 45,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 78,414 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 71,028 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 13,586 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer | 2020-10-01 | 2020-10-01 | 28,795 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-07-20 | 2020-07-21 | 1,087 | $33.95 | $36.9K | 28,795 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-07-17 | 2020-07-21 | 2,437 | — | $0 | 21,938 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-07-17 | 2020-07-21 | 2,437 | — | $0 | 29,882 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-06-30 | 2020-07-01 | 6,811 | $35.10 | $239.1K | 27,445 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2020-06-29 | 2020-07-01 | 15,000 | — | $0 | 45,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award | 2020-06-29 | 2020-07-01 | 15,000 | — | $0 | 34,256 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-06-12 | 2020-06-15 | 6,756 | $30.15 | $203.7K | 19,256 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2020-06-11 | 2020-06-15 | 15,000 | — | $0 | 30,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award | 2020-06-11 | 2020-06-15 | 15,000 | — | $0 | 26,012 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-04-20 | 2020-04-21 | 1,124 | $28.97 | $32.6K | 11,012 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-04-17 | 2020-04-21 | 2,438 | — | $0 | 24,375 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-04-17 | 2020-04-21 | 2,438 | — | $0 | 12,136 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-03-06 | 2020-03-09 | 5,302 | $29.00 | $153.8K | 9,698 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2020-03-05 | 2020-03-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award | 2020-03-05 | 2020-03-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-02-14 | 2020-02-19 | 6,892 | $31.54 | $217.4K | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-02-13 | 2020-02-14 | 3,108 | $30.03 | $93.3K | 6,892 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-02-12 | 2020-02-14 | 10,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-02-12 | 2020-02-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2020-02-07 | 2020-02-11 | 37,500 | — | $0 | 37,500 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2020-02-07 | 2020-02-11 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-01-22 | 2020-01-24 | 1,577 | $28.98 | $45.7K | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-01-21 | 2020-01-22 | 860 | $30.08 | $25.9K | 1,577 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-01-17 | 2020-01-22 | 2,437 | — | $0 | 26,813 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-01-17 | 2020-01-22 | 2,437 | — | $0 | 2,437 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-10-21 | 2019-10-23 | 6,814 | $14.40 | $98.1K | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-10-18 | 2019-10-21 | 2,936 | $13.83 | $40.6K | 6,814 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2019-10-17 | 2019-10-21 | 9,750 | — | $0 | 29,250 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2019-10-17 | 2019-10-21 | 9,750 | — | $0 | 9,750 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-04-29 | 2019-05-01 | 10,384 | $14.77 | $153.4K | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer | 2019-04-13 | 2019-04-16 | 4,725 | — | $0 | 10,383 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer | 2019-04-13 | 2019-05-14 | 4,724 | — | $0 | 10,384 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-02-14 | 2019-02-19 | 703 | $13.10 | $9.2K | 15,108 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2019-02-13 | 2019-02-14 | 2,938 | $12.70 | $37.3K | 15,811 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2019-02-12 | 2019-02-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2019-02-12 | 2019-02-14 | 10,000 | — | $0 | 18,749 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2019-02-11 | 2019-02-13 | 92,000 | — | $0 | 92,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-10-17 | 2018-10-19 | 39,000 | — | $0 | 39,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2017-01-05 | 2017-01-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2017-01-05 | 2017-01-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2016-08-22 | 2016-08-23 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2016-01-05 | 2016-01-07 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2015-12-01 | 2015-12-03 | 158,000 | — | $0 | 158,000 | SEC↗ |